RADNOR, PA / ACCESSWIRE / June 3, 2024 / The law firm of Kessler Topaz Meltzer & Check, LLP (www.ktmc.com) informs investors that a securities class action lawsuit has been filed in the United States ...

The post AKRO Stock Earnings: Akero Therapeutics Beats EPS for Q1 2024 appeared first on InvestorPlace. Akero Therapeutics NewsMORE Related Stocks Indices Commodities Currencies Stocks ...

BofA Securities raised the price target for the Akero Therapeutics Inc (NASDAQ:AKRO) stock to “a Neutral”. The rating was released on April 22, 2024, according to finviz. The research report from UBS ...

Akero Therapeutics success in HARMONY Phase 2b ... Other Big Stocks Moving Higher In Monday's Pre-Market Session U.S. stock futures were mixed this morning, with the Dow futures trading lower ...

Browse analyst ratings and price targets on all stocks.

May 08, 2024 (GLOBE NEWSWIRE) -- Akero Therapeutics, Inc. (Nasdaq ... public offering of 12,650,000 shares of its common stock at a public offering price of $29.00 per share, which includes ...

noting that the new price target represents approximately 80% upside from the stock's current trading levels. Akero Therapeutics is now in what the analyst describes as "execution mode," as it ...

Radnor, Pennsylvania--(Newsfile Corp. - June 1, 2024) - The law firm of Kessler Topaz Meltzer & Check, LLP (www.ktmc.com) informs investors that a securities class action lawsuit has been filed in the ...

The firm's analyst highlighted the potential for significant growth, noting that the new price target represents approximately 80% upside from the stock's current trading levels. Akero Therapeutics is ...